Bakhu Holdings, Corp. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024
March 25, 2024 at 04:50 pm EDT
Share
Bakhu Holdings, Corp. reported earnings results for the second quarter and six months ended January 31, 2024. For the second quarter, the company reported net loss was USD 0.12068 million compared to USD 3.14 million a year ago.
For the six months, net loss was USD 1.25 million compared to USD 6.91 million a year ago.
Bakhu Holdings, Corp. is a development-stage company. The Company hold a license from Cell Science to plant cell-extraction and replication technology and related equipment, processes, and formulations (the Licensed Science), to produce, manufacture, and sell cannabis-related byproducts - sometimes referred to as cannabinoids in North America, Central America, and the Caribbean for medical, food additive, and recreational uses. The Company is focused on testing and commercializing cannabis plant cell-extraction and replication technologies under a technology license granted by Cell Science. It also intends to sublicense the Licensed Science to third party sub-licensees. The Company has not generated any revenue.
BAKHU HOLDINGS, CORP. 
